Literature DB >> 17268896

Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom.

George Lee1, Kakahama Attar, Marc Laniado, Omer Karim.   

Abstract

INTRODUCTION: TRUS-guided needle biopsy of the prostate is the standard technique in the diagnosis of prostate cancer. However the practice is highly variable across the United Kingdom. We survey the standard approaches to TRUS biopsy of prostate, highlighting the nationwide diversity of practice and training.
METHODS: One hundred and eighty questionnaires were sent out to specialist registrars, investigating the number of prostate biopsy cores taken, the use of prophylactic antibiotics, rectal preparation and local analgesia in TRUS biopsy of the prostate. One hundred and fourteen trainees (63%) returned the questionnaires. Twenty-three percent reported sextant biopsy as standard, 36% taking eight-core and 26% taking 10 or more cores. There is no standard regime for antibiotic prophylaxis. Eighteen percent also reported rectal preparation as routine. Thirty-eight percent of the patients receive local anaesthesia prior to the biopsy. Overall, 42% of the TRUS biopsies are carried out by urologists, 29% by radiologists and 21% by both. Six percents have nurse practitioners' involvement. Fifty-six percent of trainees are involve in the TRUS biopsy, 68% do not think they received enough training to carry out the procedure.
CONCLUSIONS: TRUS-guided needle biopsy of the prostate is the standard technique in the diagnosis of prostate cancer. Our survey highlights nationwide diversity in practice in the UK with respect of the number of cores taken, antibiotic prophylaxis and local anaesthesia utilisation. This raised the issue of standardising the practice. More urologists are also actively taking part in this procedure, making the structured training increasingly important.

Entities:  

Mesh:

Year:  2007        PMID: 17268896     DOI: 10.1007/s11255-006-6654-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

Review 1.  The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy.

Authors:  H M Taylor; J B Bingham
Journal:  Clin Radiol       Date:  1997-10       Impact factor: 2.350

2.  Local anaesthetic for transrectal ultrasound-guided prostate biopsy: a prospective, randomized, double blind, placebo-controlled study.

Authors:  S K Addla; A A B Adeyoju; G D Wemyss-Holden; D Neilson
Journal:  Eur Urol       Date:  2003-05       Impact factor: 20.096

3.  Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy.

Authors:  K A Lindert; J N Kabalin; M K Terris
Journal:  J Urol       Date:  2000-07       Impact factor: 7.450

4.  Increased accuracy of biopsy Gleason score obtained by extended needle biopsy.

Authors:  P Emiliozzi; S Maymone; A Paterno; P Scarpone; M Amini; G Proietti; M Cordahi; V Pansadoro
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

5.  Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study.

Authors:  M Aron; T P Rajeev; N P Gupta
Journal:  BJU Int       Date:  2000-04       Impact factor: 5.588

6.  Effect of periprostatic nerve blockade before transrectal ultrasound-guided prostate biopsy on patient comfort: a randomized placebo controlled study.

Authors:  Gurdal Inal; Sertaac Yazici; Oztug Adsan; Bulent Ozturk; Murat Kosan; Mesut Cetinkaya
Journal:  Int J Urol       Date:  2004-03       Impact factor: 3.369

7.  Nitrous oxide (Entonox) inhalation and tolerance of transrectal ultrasound guided prostate biopsy: a double-blind randomized controlled study.

Authors:  J Masood; N Shah; T Lane; H Andrews; P Simpson; J M Barua
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

8.  Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy.

Authors:  D A Kapoor; I W Klimberg; G H Malek; J D Wegenke; C E Cox; A L Patterson; E Graham; R M Echols; E Whalen; S F Kowalsky
Journal:  Urology       Date:  1998-10       Impact factor: 2.649

9.  Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk.

Authors:  Brian C Griffith; Allen F Morey; Mustafa M Ali-Khan; Edith Canby-Hagino; John P Foley; Thomas A Rozanski
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

10.  Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol.

Authors:  Khurshid R Ghani; Derek Dundas; Uday Patel
Journal:  BJU Int       Date:  2004-11       Impact factor: 5.588

View more
  11 in total

1.  CUA guidelines on prostate biopsy methodology.

Authors:  Assaad El-Hakim; Sabri Moussa
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

2.  Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis.

Authors:  Lana Pepdjonovic; Guan Hee Tan; Sean Huang; Sarah Mann; Mark Frydenberg; Daniel Moon; Uri Hanegbi; Adam Landau; Ross Snow; Jeremy Grummet
Journal:  World J Urol       Date:  2016-12-16       Impact factor: 4.226

3.  Does periprostatic block reduce pain during transrectal prostate biopsy? A randomized, placebo-controlled, double-blinded study.

Authors:  Michael S Ingber; Ibrahim Ibrahim; Cynthia Turzewski; Jay B Hollander; Ananias C Diokno
Journal:  Int Urol Nephrol       Date:  2009-08-08       Impact factor: 2.370

4.  Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study.

Authors:  Riccardo Bartoletti; Francesco Claps; Gabriele Tulone; Alessandro Perotti; Alessandro Zucchi; Niccolò Riccardi; Vincenzo Ficarra; Cosimo De Nunzio; Andrea Tubaro; Alchiede Simonato
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

5.  Applications of transrectal ultrasound in prostate cancer.

Authors:  C J Harvey; J Pilcher; J Richenberg; U Patel; F Frauscher
Journal:  Br J Radiol       Date:  2012-07-27       Impact factor: 3.039

6.  Risk factors for acute prostatitis after transrectal biopsy of the prostate.

Authors:  Sang Jin Kim; Sun Il Kim; Hyun Soo Ahn; Jong Bo Choi; Young Soo Kim; Se Joong Kim
Journal:  Korean J Urol       Date:  2010-06-21

7.  The association of level of practical experience in transrectal ultrasonography guided prostate biopsy with its diagnostic outcome.

Authors:  S Tadtayev; A Hussein; L Carpenter; N Vasdev; G Boustead
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

8.  Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Julia Wade; Sian Noble; Kirsty Garfield; Grace Young; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Jane Blazeby; Richard Bryant; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Vincent Gnanapragasam; Owen Hughes; Roger Kockelbergh; Howard Kynaston; Alan Paul; Edgar Paez; Philip Powell; Stephen Prescott; Derek Rosario; Edward Rowe; David Neal
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

9.  Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

Authors:  Derek J Rosario; J Athene Lane; Chris Metcalfe; Jenny L Donovan; Andy Doble; Louise Goodwin; Michael Davis; James W F Catto; Kerry Avery; David E Neal; Freddie C Hamdy
Journal:  BMJ       Date:  2012-01-09

10.  Risk factors for infection following prostate biopsy - a case control study.

Authors:  Elliot Anderson; Olivia Leahy; Allen C Cheng; Jeremy Grummet
Journal:  BMC Infect Dis       Date:  2015-12-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.